Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica P Cahill

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|August 19, 2023
Adding a COX-2 inhibitor improves efficacy of emergency contraceptionErica P Cahill
Current Opinion in Obstetrics & Gynecology|February 5, 2026
The new toolbox for reducing painful sex in menopauseErica P Cahill
Current Opinion in Obstetrics & Gynecology|November 7, 2019
Self-managed abortionJennifer Conti, Erica P Cahill
Current Opinion in Obstetrics & Gynecology|September 24, 2020
Advances in contraception research and developmentErica P Cahill, Simranvir Kaur
Current Opinion in Obstetrics & Gynecology|November 8, 2021
Trauma-informed abortion careErica P Cahill, Alexis Doyle
Current Opinion in Obstetrics & Gynecology|September 17, 2025
#Birth control: contraception conversations on social mediaJayne Caron, Erica P Cahill
Current Opinion in Obstetrics & Gynecology|November 7, 2018
Pericoital contraceptionErica P Cahill, Paul D Blumenthal
Current Opinion in Obstetrics & Gynecology|November 7, 2022
The ongoing crisis of abortion care education and training in the United StatesErica P Cahill, Pamela K Meza
Contraception|September 14, 2025
Society of Family Planning Research Practice Support: Digital and data security for abortion research in a post-Dobbs era-A primer for qualitative researchersMelissa Madera, Amanda Bennett, Katherine Bertash, et al.
BMJ Sexual & Reproductive Health|April 26, 2022
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruptionErica P Cahill, Klaira Lerma, Kate A Shaw, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|August 19, 2023
Adding a COX-2 inhibitor improves efficacy of emergency contraceptionErica P Cahill
Current Opinion in Obstetrics & Gynecology|February 5, 2026
The new toolbox for reducing painful sex in menopauseErica P Cahill
Current Opinion in Obstetrics & Gynecology|November 7, 2019
Self-managed abortionJennifer Conti, Erica P Cahill
Current Opinion in Obstetrics & Gynecology|September 24, 2020
Advances in contraception research and developmentErica P Cahill, Simranvir Kaur
Current Opinion in Obstetrics & Gynecology|November 8, 2021
Trauma-informed abortion careErica P Cahill, Alexis Doyle
Current Opinion in Obstetrics & Gynecology|September 17, 2025
#Birth control: contraception conversations on social mediaJayne Caron, Erica P Cahill
Current Opinion in Obstetrics & Gynecology|November 7, 2018
Pericoital contraceptionErica P Cahill, Paul D Blumenthal
Current Opinion in Obstetrics & Gynecology|November 7, 2022
The ongoing crisis of abortion care education and training in the United StatesErica P Cahill, Pamela K Meza
Contraception|September 14, 2025
Society of Family Planning Research Practice Support: Digital and data security for abortion research in a post-Dobbs era-A primer for qualitative researchersMelissa Madera, Amanda Bennett, Katherine Bertash, et al.
BMJ Sexual & Reproductive Health|April 26, 2022
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruptionErica P Cahill, Klaira Lerma, Kate A Shaw, et al.
Pageof 3